In Slugterra: Slug It Out 2 we'll once again take on the role of Eli Shane that, together with his friends Pronto, Trixie, and Kord, and your invaluable help, will become an expert slug thrower in ...

In the case of Eli Manning, you cannot. And while Peyton’s overall career might be better, Eli got a leg up on older brother when he won his second Super Bowl MVP following the 2011 season ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

Eli Manning does not recall ever thinking about the Hall of Fame, or bringing it up in conversations. “Never really talked about it with my wife, really,” he told The Post. Until recently ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

One of the five players on the ballot for the first time is Eli Manning. Sure thing? Surely, not. Based on conversations with several voters, the former Giants quarterback and two-time Super Bowl ...